menu search

SYNH / Syneos Health's (SYNH) New Microsoft Deal to Expand AI Usage

Syneos Health's (SYNH) New Microsoft Deal to Expand AI Usage
With the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft. Read More
Posted: Mar 21 2023, 10:43
Author Name: Zacks Investment Research
Views: 110880

SYNH News  

Syneos Health (SYNH) Declares Strategic Partnership With Oracle

By Zacks Investment Research
September 13, 2023

Syneos Health (SYNH) Declares Strategic Partnership With Oracle

Syneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities. more_horizontal

Syneos Health (SYNH) Collaborates With uMotif for New Platform

By Zacks Investment Research
June 27, 2023

Syneos Health (SYNH) Collaborates With uMotif for New Platform

Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform. more_horizontal

Syneos Health (SYNH) Sell-Off Appears Strategic Amid Margin Woes

By Zacks Investment Research
June 7, 2023

Syneos Health (SYNH) Sell-Off Appears Strategic Amid Margin Woes

Syneos Health's (SYNH) purchase price represents a 24% premium to its unaffected closing stock price prior to the announcement. Margin pressure contin more_horizontal

Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates

By Zacks Investment Research
May 10, 2023

Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates

Syneos Health (SYNH) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to ea more_horizontal

Syneos Health's stock soars 19% on acquisition report

By Market Watch
May 9, 2023

Syneos Health's stock soars 19% on acquisition report

Syneos Health Inc.'s SYNH stock surged 19% in extended trading Tuesday on a Bloomberg report that a consortium of Elliott Investment Management, Patie more_horizontal

Here's Why Investors Should Retain Syneos Health (SYNH) for Now

By Zacks Investment Research
May 8, 2023

Here's Why Investors Should Retain Syneos Health (SYNH) for Now

Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-ad more_horizontal

Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023

By GlobeNewsWire
April 13, 2023

Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023

MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organizati more_horizontal

Syneos Health: Rumors Of Private Equity Circling, Potential 40% Upside

By Seeking Alpha
April 12, 2023

Syneos Health: Rumors Of Private Equity Circling, Potential 40% Upside

Dealreporter article says that multiple PE firms are bidding for the company and even named advisors the company has hired. Private equity math works more_horizontal


Search within

Pages Search Results: